Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii.

Kedzierski, L

Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii. [electronic resource] - Vaccine Sep 2001 - 4661-8 p. digital

Publication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

0264-410X

10.1016/s0264-410x(01)00244-4 doi


Animals
Antibodies, Protozoan--biosynthesis
Antigens, Protozoan--biosynthesis
Escherichia coli--metabolism
Female
Immunoglobulin G--biosynthesis
Immunoglobulin Isotypes--biosynthesis
Malaria--immunology
Malaria Vaccines--biosynthesis
Membrane Proteins--biosynthesis
Mice
Mice, Inbred BALB C
Parasitemia--immunology
Plasmodium yoelii--genetics
Protein Structure, Tertiary
Protozoan Proteins--biosynthesis
Recombinant Fusion Proteins--biosynthesis
Saccharomyces cerevisiae--metabolism
Species Specificity
Structure-Activity Relationship
Vaccination